Slide background

> Our Technology

DCVax® is a platform
technology that uses
activated dendritic cells

Slide background

> Our Products

DCVax® – L
DCVax® – Direct
DCVax® – Prostate

Slide background

Northwest Biotherapeutics, Inc is a clinical stage biotechnology company focused on the development of personalized cancer vaccines designed to treat a broad range of solid tumor cancers.

DCVax-L Patients From UCLA

UCLA Department of Neurosurgery

Dr. Linda Liau discusses our DCVax-L clinical trial for glioblastoma brain cancer and describes the positive impact it has had on patients. Brad and Jennifer share their stories about diagnosis and their choice to receive DCVax.

Proxy Statement